TITLE

Duchenne muscular dystrophy, cystic fibrosis, myotonic dystrophy: gene to protein

AUTHOR(S)
Robinson, Alex
PUB. DATE
June 1993
SOURCE
CMAJ: Canadian Medical Association Journal;6/1/1993, Vol. 148 Issue 11, p1975
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35491927

 

Related Articles

  • Autonomic regulation in muscular dystrophy. Angelini, Corrado; Di Leo, Rita; Cudia, Paola // Frontiers in Physiology;Sep2013, Vol. 4, p1 

    The article discusses the assessment of autonomic nervous system (ANS) function in muscular dystrophies. Topics discussed include the relationship between ANS and cardiac mortality, types of muscular dystrophies such as Duchenne (DMD) and Becker (BMD) muscular dystrophies, myotonic dystrophy,...

  • Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast... Gussoni, E.; Pavlath, G.K. // Nature;4/2/1992, Vol. 356 Issue 6368, p435 

    Tests the possibility of gene delivery by transplantation of normal myoblasts as a treatment of the primary defect that causes Duchenne muscular dystrophy. Lack of the muscle protein dystrophin as the primary defect in Duchenne muscular dystrophy; Muscle degenerative disorders; Methods;...

  • Cut the nonsense.  // New Scientist;4/28/2007, Vol. 194 Issue 2601, p16 

    The author discusses the use of medication to overcome gene mutations that cause diseases such as cystic fibrosis and Duchenne muscular dystrophy. Details related to study results supporting the use of the antibiotic gentamicin and a new drug that restored muscle function in a mouse model and...

  • The Genome Structure and DNA Diagnosis of Monogenic Hereditary Disorders in the Volga—Ural Region. Khidiyatova, I. M.; Khusnutdinova, E. K. // Molecular Biology;Jan/Feb2004, Vol. 38 Issue 1, p119 

    The review considers the main results of molecular analysis of the genes responsible for cystic fibrosis, phenylketonuria, Wilson–Konovalov disease, Duchenne–Becker progressive muscular dystrophy, myotonic dystrophy, Huntington's disease, and non-syndromic hereditary deafness in...

  • Screening of the Newborn for Duchenne Muscular Dystrophy.  // British Medical Journal;5/24/1975, Vol. 2 Issue 5968, p403 

    Proposes a method for the routine screening of newborn male infants for duchenne muscular dystrophy. Significance of serum creatine phosphokinase activity in detecting gene carriers; Details of duchenne muscular dystrophy; Treatment for duchenne; Management of patients with neuromuscular diseases.

  • SEPTEMBER IS MUSCULAR DYSTROPHY AWARENESS MONTH.  // Canadian Nurse;Sep2012, Vol. 108 Issue 7, p10 

    The article presents some numbers about muscular dystrophy since September is muscular dystrophy awareness month; 0 number of specific treatments available for muscular dystrophy, 1 in 8,000 people worldwide affected by myotonic dystrophy and 14 the age at which 82 percent of boys with Duchenne...

  • The Becker type X-linked muscular dystrophy.  // British Medical Journal;12/18/1976, Vol. 2 Issue 6050, p1465 

    Examines the different forms of muscular dystrophy in Great Britain. Difficulties brought by Duchenne muscular dystrophy; Comparison between Duchenne and Becker muscular dystrophy; Presence of cardiomyopathy in Duchenne muscular dystrophy.

  • Respiratory care in muscular dystrophy. Heckmatt, J.Z. // British Medical Journal (Clinical Research Edition);10/24/1987, Vol. 295 Issue 6605, p1014 

    Examines the respiratory care in Duchenn muscular dystrophy in Great Britain. Description of Duchenn muscular dystrophy; Symptoms of the disease; Causes of the disease.

  • A sea urchin gene encoding dystrophin-related proteins. Wang, Jun; Pansky, Avi; Venuti, Judith M.; Yaffe, David; Nudel, Uri // Human Molecular Genetics;Apr98, Vol. 7 Issue 4, p581 

    Studies a sea urchin gene encoding dystrophin-related proteins. Gene defective in Duchenne muscular dystrophy; Two non-muscle dystrophin isoforms; Four smaller proteins transcribed from internal promoters.

  • Stem cells reverse muscular dystrophy. Mackenzie, Debora // New Scientist;11/18/2006, Vol. 192 Issue 2578, p12 

    The article presents information related to the treatment of Duchenne muscular dystrophy (DMD). Adult stem cells called mesangioblasts have helped dogs with muscular dystrophy to walk again. So, doctors hopes that a similar approach in humans can cure the disease in human. DMD is caused by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics